Senaptec
- Industry
- Biotechnology
- Founded Year
- 2013
- Headquarters
- Beaverton, Oregon, United States
- Employee Count
- 19
Key People
- Joseph Bingold - Co-Founder, Chief Executive Officer, President & Board Member
- Herb Yoo - Co-Founder, Chief Technology Officer & Board Member
- Jason Mihalik - Co-Founder, Chief Scientific Officer & Board Member
- Pete Naschak - Co-Founder, Vice President of Elite Programs & Board Member
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The founding team comprises experienced professionals with backgrounds in technology and scientific research.
The leadership team includes individuals with significant experience in technology and scientific research, contributing to the company's strong foundation and innovative product development.
- Clinical Need
-
Aspect: Good
Summary: Senaptec addresses the need for tools to assess and improve brain health and performance, focusing on sensorimotor skills.
The company's products cater to athletes and individuals undergoing rehabilitation, offering solutions to enhance vision and motor response. However, the niche market and competition may limit widespread adoption.
- Competition
-
Aspect: Somewhat crowded
Summary: The market for sensory performance tools includes several competitors offering similar products.
While Senaptec offers innovative products, the market has other companies providing comparable solutions, which could impact the company's ability to differentiate and capture a larger market share.
- Technical Challenge
-
Aspect: Predictable
Summary: The development of sensory performance tools involves manageable technical challenges.
Senaptec's focus on sensorimotor skills and the use of existing technologies suggest that the technical challenges are within the company's capabilities, allowing for efficient product development.
- Patent
-
Aspect: Strong
Summary: Senaptec holds multiple patents related to its sensory performance technologies.
With several patents granted, Senaptec has established a strong intellectual property position, which can serve as a barrier to entry for competitors and protect its innovations.
- Financing
-
Aspect: Medium
Summary: Senaptec has secured funding from investors, including Carolina Angel Network and Stadia Ventures.
The financial backing from reputable investors provides Senaptec with the necessary resources to develop and market its products, contributing to its overall success and market penetration.
- Regulatory
-
Aspect: 510k/PMA
Summary: Senaptec's products are subject to regulatory approvals, including 510(k) clearance or PMA.
Compliance with regulatory requirements ensures product safety and efficacy, which is essential for gaining market acceptance and trust among consumers and healthcare professionals.
Opportunity Rollup
- Odds of Success
- 3.25
- Peak Market Share
- 4.4
- Segment CAGR
- 4.9%
- Market Segment
- Neurology Devices
- Market Sub Segment
- Sensorimotor Assessment and Training Tools
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.22 |
| 2 | 0.66 |
| 3 | 1.54 |
| 4 | 3.08 |
| 5 | 4.40 |
Key Takeaway
Senaptec, with its experienced team and innovative products, is well-positioned in the growing brain health and performance market, though it faces challenges from competition and regulatory requirements.